fda compounding semaglutide warning 2025 october Beyond the Headlines: Letters to GLP-1 Compounders FDA Drug Recalls and Warnings:

Under current delivery methods, successful transdermal drugs typically have a molecular weight of only a few hundred Daltons, with an octanol-water partition coefficient favoring lipids, and require daily doses of milligrams or less

Current evidence suggests that most patients who tolerate treatment during the first year continue to do well later

Check protein intake Low protein intake during weight loss causes disproportionate lean mass loss, which lowers resting metabolic rate, which slows further weight loss

Briyal S, Shah S, Gulati A (2014) Neuroprotective and anti-apoptotic effects of liraglutide in the rat brain following focal cerebral ischemia

Available from: Post SM, Persky S